Volume 51, issue 3, March 2008

22 articles in this issue

Aspirin resistance and diabetes mellitus

Authors
- R. Ajjan
- R. F. Storey
- P. J. Grant
- Content type: Commentary
- Published: 16 January 2008
- Pages: 385 - 390
Candidate gene studies reveal that the WFS1 gene joins the expanding list of novel type 2 diabetes genes

Authors
- J. Wasson
- M. A. Permutt
- Content type: Commentary
- Published: 15 January 2008
- Pages: 391 - 393
Fatty acid-induced mitochondrial uncoupling in adipocytes is not a promising target for treatment of insulin resistance unless adipocyte oxidative capacity is increased

Authors
- K. N. Frayn
- D. Langin
- F. Karpe
- Content type: For Debate
- Published: 21 December 2007
- Pages: 394 - 397
Exercise: the brittle cornerstone of type 2 diabetes treatment

Authors
- S. F. E. Praet
- L. J. C. van Loon
- Content type: For Debate
- Open Access
- Published: 09 January 2008
- Pages: 398 - 401
Can persistent organic pollutants explain the association between serum γ-glutamyltransferase and type 2 diabetes?

Authors
- D.-H. Lee
- M. W. Steffes
- D. R. Jacobs Jr.
- Content type: For Debate
- Published: 11 December 2007
- Pages: 402 - 407
A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

Authors (first, second and last of 6)
- J. Rosenstock
- M. Davies
- G. Schernthaner
- Content type: Article
- Open Access
- Published: 16 January 2008
- Pages: 408 - 416
The effects of type 1 diabetes on cerebral white matter

Authors (first, second and last of 7)
- K. Weinger
- A. M. Jacobson
- P. F. Renshaw
- Content type: Article
- Published: 18 December 2007
- Pages: 417 - 425
Effects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes

Authors (first, second and last of 8)
- M. L. Koivikko
- M. Karsikas
- J. S. Perkiömäki
- Content type: Article
- Published: 19 December 2007
- Pages: 426 - 435
Pre-morbid intelligence, the metabolic syndrome and mortality: the Vietnam Experience Study

Authors (first, second and last of 6)
- G. D. Batty
- C. R. Gale
- I. J. Deary
- Content type: Article
- Published: 18 January 2008
- Pages: 436 - 443
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients

Authors (first, second and last of 7)
- G. Targher
- L. Bertolini
- M. Muggeo
- Content type: Article
- Published: 06 December 2007
- Pages: 444 - 450
Testing of diabetes-associated WFS1 polymorphisms in the Diabetes Prevention Program

Authors (first, second and last of 10)
- J. C. Florez
- K. A. Jablonski
- for the Diabetes Prevention Program Research Group
- Content type: Article
- Published: 04 December 2007
- Pages: 451 - 457
Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations

Authors (first, second and last of 14)
- P. W. Franks
- O. Rolandsson
- M. S. Sandhu
- Content type: Article
- Published: 27 November 2007
- Pages: 458 - 463
USF1 gene variants contribute to metabolic traits in men in a longitudinal 32-year follow-up study

Authors (first, second and last of 10)
- K. Auro
- K. Kristiansson
- A.-C. Syvänen
- Content type: Article
- Published: 21 December 2007
- Pages: 464 - 472
The association between the IFIH1 locus and type 1 diabetes

Authors (first, second and last of 4)
- H.-Q. Qu
- L. Marchand
- C. Polychronakos
- Content type: Short Communication
- Published: 11 December 2007
- Pages: 473 - 475
Presence of functional cannabinoid receptors in human endocrine pancreas

Authors (first, second and last of 13)
- F. J. Bermúdez-Silva
- J. Suárez
- F. Rodríguez de Fonseca
- Content type: Article
- Published: 19 December 2007
- Pages: 476 - 487
Autoantibodies to IA-2β improve diabetes risk assessment in high-risk relatives

Authors (first, second and last of 7)
- P. Achenbach
- E. Bonifacio
- ENDIT Group
- Content type: Short Communication
- Published: 09 January 2008
- Pages: 488 - 492
Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS)

Authors (first, second and last of 5)
- S. S. Soedamah-Muthu
- N. Chaturvedi
- and the EURODIAB Prospective Complications Study Group
- Content type: Article
- Open Access
- Published: 09 January 2008
- Pages: 493 - 501
Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study

Authors (first, second and last of 18)
- M. Laakso
- J. Zilinskaite
- for the EUGENE2 Consortium
- Content type: Article
- Published: 14 December 2007
- Pages: 502 - 511
Isoform-specific defects of insulin stimulation of Akt/protein kinase B (PKB) in skeletal muscle cells from type 2 diabetic patients

Authors (first, second and last of 7)
- D. Cozzone
- S. Fröjdö
- H. Vidal
- Content type: Article
- Published: 18 January 2008
- Pages: 512 - 521
Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy

Authors (first, second and last of 7)
- D. M. Nathan
- J. B. Buse
- B. Zinman
- Content type: Erratum
- Published: 12 January 2008
- Pages: 522 - 522
Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations

Authors (first, second and last of 14)
- P. W. Franks
- O. Rolandsson
- M. S. Sandhu
- Content type: Erratum
- Published: 15 January 2008
- Pages: 523 - 523
Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus

Authors (first, second and last of 10)
- A. Imagawa
- T. Hanafusa
- H. Makino
- Content type: Erratum
- Published: 09 January 2008
- Pages: 524 - 526

Volume 51, issue 3, March 2008

Aspirin resistance and diabetes mellitus

Candidate gene studies reveal that the WFS1 gene joins the expanding list of novel type 2 diabetes genes

Fatty acid-induced mitochondrial uncoupling in adipocytes is not a promising target for treatment of insulin resistance unless adipocyte oxidative capacity is increased

Exercise: the brittle cornerstone of type 2 diabetes treatment

Can persistent organic pollutants explain the association between serum γ-glutamyltransferase and type 2 diabetes?

A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

The effects of type 1 diabetes on cerebral white matter

Effects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes

Pre-morbid intelligence, the metabolic syndrome and mortality: the Vietnam Experience Study

Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients

Testing of diabetes-associated WFS1 polymorphisms in the Diabetes Prevention Program

Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations

USF1 gene variants contribute to metabolic traits in men in a longitudinal 32-year follow-up study

The association between the IFIH1 locus and type 1 diabetes

Presence of functional cannabinoid receptors in human endocrine pancreas

Autoantibodies to IA-2β improve diabetes risk assessment in high-risk relatives

Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS)

Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study

Isoform-specific defects of insulin stimulation of Akt/protein kinase B (PKB) in skeletal muscle cells from type 2 diabetic patients

Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy

Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations

Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus

For authors

Explore

Volume 51, issue 3, March 2008

Authors

Authors

Authors

Authors

Authors

Authors (first, second and last of 6)

Authors (first, second and last of 7)

Authors (first, second and last of 8)

Authors (first, second and last of 6)

Authors (first, second and last of 7)

Authors (first, second and last of 10)

Authors (first, second and last of 14)

Authors (first, second and last of 10)

Authors (first, second and last of 4)

Authors (first, second and last of 13)

Authors (first, second and last of 7)

Authors (first, second and last of 5)

Authors (first, second and last of 18)

Authors (first, second and last of 7)

Authors (first, second and last of 7)

Authors (first, second and last of 14)

Authors (first, second and last of 10)

For authors

Explore